BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17313602)

  • 1. A randomised controlled trial comparing the routine use of an Angio-Seal STS device strategy with conventional femoral haemostasis methods in a district general hospital.
    Behan MW; Large JK; Patel NR; Lloyd GW; Sulke AN
    Int J Clin Pract; 2007 Mar; 61(3):367-72. PubMed ID: 17313602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial.
    Martin JL; Pratsos A; Magargee E; Mayhew K; Pensyl C; Nunn M; Day F; Shapiro T
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):1-5. PubMed ID: 18098171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital--the SCOAST study.
    Veasey RA; Large JK; Silberbauer J; Paul G; Taggu W; Ellery S; Rathore VS; Lloyd GW; Patel NR; Sulke AN
    Int J Clin Pract; 2008 Jun; 62(6):912-8. PubMed ID: 18479284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices.
    Duffin DC; Muhlestein JB; Allisson SB; Horne BD; Fowles RE; Sorensen SG; Revenaugh JR; Bair TL; Lappe DL
    J Invasive Cardiol; 2001 May; 13(5):354-62. PubMed ID: 11385148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of closure strategies after balloon aortic valvuloplasty: suture mediated versus collagen based versus manual.
    Ben-Dor I; Looser P; Bernardo N; Maluenda G; Torguson R; Xue Z; Lindsay J; Pichard AD; Satler LF; Waksman R
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):119-24. PubMed ID: 21681898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression.
    Deuling JH; Vermeulen RP; Anthonio RA; van den Heuvel AF; Jaarsma T; Jessurun G; de Smet BJ; Tan ES; Zijlstra F
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):518-23. PubMed ID: 18307223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid hemostasis of arterial puncture sites with Angio-Seal in patients undergoing percutaneous coronary intervention.
    Trisnohadi HB
    Acta Med Indones; 2005; 37(2):87-90. PubMed ID: 20066791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
    Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinksi EJ; Roubin GS
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():6B-13B. PubMed ID: 10745611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective nonrandomized trial of manual compression and Angio-Seal and Starclose arterial closure devices in common femoral punctures.
    Ratnam LA; Raja J; Munneke GJ; Morgan RA; Belli AM
    Cardiovasc Intervent Radiol; 2007; 30(2):182-8. PubMed ID: 17200896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femoral Arterial Hemostasis using the Angio-Sealª System after Coronary and Vascular Percutaneous Angioplasty and Stenting.
    Cremonesi A; Castriota F; Tarantino F; Troiani E; Ricci E; El Jamal B ; Grattoni C; Noera G
    J Invasive Cardiol; 1998 Oct; 10(8):464-469. PubMed ID: 10762823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial.
    Zhang Z; Mahoney EM; Gershony G; Ellis S; Saucedo JF; Talley JD; Feldman T; Weintraub WS
    Am Heart J; 2001 Dec; 142(6):982-8. PubMed ID: 11717601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device.
    Eggebrecht H; Naber C; Woertgen U; Ringe S; Konorza TF; Schmermund A; von Birgelen C; Haude M; Kroeger K; Erbel R; Baumgart D
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):313-21. PubMed ID: 12594694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of hemostatic puncture closing device for hemostasis and early ambulation after coronary angiography and angioplasty: results of a multicenter trial].
    Magosaki N; Hosoda S; Kawagishi N; Yamaguchi T; Sakatani H; Haze K; Itagane H; Otsuka M; Nobuyoshi M; Yokoi H
    J Cardiol; 1999 Sep; 34(3):131-8. PubMed ID: 10500973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization.
    Doyle BJ; Godfrey MJ; Lennon RJ; Ryan JL; Bresnahan JF; Rihal CS; Ting HH
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):203-8. PubMed ID: 17195965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The experience with the Epiclose-T vascular access closure device: a human study.
    Kurşaklioğlu H; Iyisoy A; Barçin C; Celik T; Nitzan R; Köse S; Amasyali B; Işik E
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):38-42. PubMed ID: 18258532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of a novel vascular closure device: a prospective study of the ExoSeal compared to the Angio-Seal and ProGlide.
    Kara K; Mahabadi AA; Rothe H; Müller P; Krüger J; Neubauer H; Klein-Wiele O; Mügge A; Kahlert P; Erbel R
    J Endovasc Ther; 2014 Dec; 21(6):822-8. PubMed ID: 25453885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized single-blind trial of patient comfort following vessel closure: extravascular synthetic sealant closure provides less pain than a self-tightening suture vascular compression device.
    Fargen KM; Hoh BL; Mocco J
    J Neurointerv Surg; 2011 Sep; 3(3):219-23. PubMed ID: 21990828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular occlusion as a late complication of the Angio-Seal closure device. A review of literature.
    Van Den Broek T; Liqui Lung PF; Suttorp MJ; Eefting FD; Schipper ME; Vink A
    Minerva Cardioangiol; 2007 Dec; 55(6):815-9. PubMed ID: 18091648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device.
    Bavry AA; Raymond RE; Bhatt DL; Chambers CE; DeNardo AJ; Hermiller JB; Myers PR; Pitts DE; Scott JA; Savader SJ; Steinhubl S
    J Invasive Cardiol; 2008 Apr; 20(4):152-6. PubMed ID: 18398227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early ambulation after percutaneous femoral access with use of closure devices and hemostatic agents.
    Engelbert TL; Scholten A; Thompson K; Spivack A; Kansal N
    Ann Vasc Surg; 2010 May; 24(4):518-23. PubMed ID: 20451795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.